Related Articles
First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
Evaluation of a trastuzumab-containing treatment regimen for patients with unresectable advanced or recurrent gastric cancer
Combined intra-arterial and intravenous chemotherapy for unresectable, advanced gastric cancer has an improved curative effect compared with intravenous chemotherapy only
Changes in neutrophil/lymphocyte and platelet/lymphocyte ratios after chemotherapy correlate with chemotherapy response and prediction of prognosis in patients with unresectable gastric cancer
Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancer